Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, New York, USA.
Beacon Epidemiology Associates, Rose Valley, Pennsylvania, USA.
J Infect Dis. 2024 Nov 15;230(5):e1007-e1011. doi: 10.1093/infdis/jiae424.
Older age and comorbid conditions increase risk for severe for respiratory syncytial virus (RSV). Skilled nursing facilities (SNFs) and assisted living (AL) facilities represent an intersection of risk factors. In a 3-year prospective study in Rochester, New York, we compared the population-based incidence of RSV-associated hospitalization for community-dwelling (CD), SNF, and AL adults aged ≥65 years. Their median ages were 76, 83 and 86 years, respectively, and dementia and congestive heart failure (CHF) were more prevalent among SNF and AL residents. The average annual incidences were 117 (95% confidence interval, 104-132), 440 (307-629) and 740 per 100 000 persons (523-1045), respectively, for CD, SNF, and AL adults aged ≥65 years, demonstrating a need for unequivocal RSV vaccine recommendations in SNF and AL residents.
老年人和合并症会增加呼吸道合胞病毒(RSV)重症感染的风险。疗养院和辅助生活设施(AL)是各种风险因素的交汇点。在纽约罗切斯特的一项为期 3 年的前瞻性研究中,我们比较了社区居住(CD)、疗养院和辅助生活设施中≥65 岁的成年人因 RSV 相关住院的基于人群的发病率。他们的中位年龄分别为 76、83 和 86 岁,疗养院和辅助生活设施的居民中痴呆症和充血性心力衰竭(CHF)更为普遍。≥65 岁的 CD、疗养院和辅助生活设施的成年人的年平均发病率分别为每 100000 人 117(95%置信区间为 104-132)、440(307-629)和 740(523-1045),这表明需要为疗养院和辅助生活设施的居民明确推荐 RSV 疫苗。